Elliot Raizes

2.0k total citations
26 papers, 369 citations indexed

About

Elliot Raizes is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Elliot Raizes has authored 26 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 16 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Elliot Raizes's work include HIV/AIDS Research and Interventions (24 papers), HIV/AIDS drug development and treatment (19 papers) and HIV Research and Treatment (16 papers). Elliot Raizes is often cited by papers focused on HIV/AIDS Research and Interventions (24 papers), HIV/AIDS drug development and treatment (19 papers) and HIV Research and Treatment (16 papers). Elliot Raizes collaborates with scholars based in United States, South Africa and Uganda. Elliot Raizes's co-authors include Catherine Godfrey, Gillian Hunt, George K. Siberry, B. Ryan Phelps, Julie A. Ake, Túlio de Oliveira, Thomas Minior, Chunfu Yang, Shannon Hader and Shahin Lockman and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and The Lancet Infectious Diseases.

In The Last Decade

Elliot Raizes

25 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elliot Raizes United States 12 333 202 91 39 37 26 369
Beth Chaplin United States 14 447 1.3× 374 1.9× 133 1.5× 30 0.8× 38 1.0× 27 549
K. Naidu South Africa 10 221 0.7× 102 0.5× 131 1.4× 32 0.8× 64 1.7× 17 289
Anne Esther Njom Nlend Cameroon 11 227 0.7× 95 0.5× 95 1.0× 54 1.4× 48 1.3× 40 291
Peter Arimi United States 7 460 1.4× 249 1.2× 175 1.9× 55 1.4× 99 2.7× 14 530
Asghar Kheshti United States 9 282 0.8× 138 0.7× 139 1.5× 25 0.6× 77 2.1× 10 325
Vincent Tukei United States 10 221 0.7× 70 0.3× 90 1.0× 51 1.3× 91 2.5× 23 261
Joyceline Kinyua Kenya 11 162 0.5× 151 0.7× 103 1.1× 104 2.7× 70 1.9× 39 397
Josephine Muhairwe Switzerland 12 452 1.4× 273 1.4× 220 2.4× 28 0.7× 92 2.5× 28 499
Roland O Swai Tanzania 7 258 0.8× 95 0.5× 130 1.4× 47 1.2× 73 2.0× 7 320
Grace Wariua Kenya 9 236 0.7× 105 0.5× 131 1.4× 56 1.4× 124 3.4× 10 352

Countries citing papers authored by Elliot Raizes

Since Specialization
Citations

This map shows the geographic impact of Elliot Raizes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elliot Raizes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elliot Raizes more than expected).

Fields of papers citing papers by Elliot Raizes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elliot Raizes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elliot Raizes. The network helps show where Elliot Raizes may publish in the future.

Co-authorship network of co-authors of Elliot Raizes

This figure shows the co-authorship network connecting the top 25 collaborators of Elliot Raizes. A scholar is included among the top collaborators of Elliot Raizes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elliot Raizes. Elliot Raizes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joseph, Rachael, Thomas Achia, Sasi Jonnalagadda, et al.. (2024). Beyond the 95s: What happens when uniform program targets are applied across a heterogenous HIV epidemic in Eastern and Southern Africa?. PLOS Global Public Health. 4(9). e0003723–e0003723.
2.
Ismael, Nália, Cheryl Baxter, Eduan Wilkinson, et al.. (2024). HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ lamivudine /dolutegravir (TLD) roll-out in Mozambique. BMC Infectious Diseases. 24(1). 748–748. 2 indexed citations
3.
Hunt, Gillian, Mukhlid Yousif, Leon Levin, et al.. (2023). Resistance is common in paediatric patients failing ART in South Africa. Journal of Antimicrobial Chemotherapy. 78(5). 1160–1167. 5 indexed citations
4.
Jordan, Michael R., Nicholus Mutenda, Gillian Hunt, et al.. (2022). Pretreatment Human Immunodeficiency Virus (HIV) Drug Resistance Among Treatment-Naive Infants Newly Diagnosed With HIV in 2016 in Namibia: Results of a Nationally Representative Study. Open Forum Infectious Diseases. 9(5). ofac102–ofac102. 3 indexed citations
5.
Silva, Juliana da, Mark J. Siedner, Suzanne M. McCluskey, et al.. (2022). Drug resistance and use of long-acting ART. The Lancet HIV. 9(6). e374–e375. 3 indexed citations
6.
Watera, Christine, Deogratius Ssemwanga, Juliet Asio, et al.. (2021). HIV drug resistance among adults initiating antiretroviral therapy in Uganda. Journal of Antimicrobial Chemotherapy. 76(9). 2407–2414. 8 indexed citations
7.
Silva, Juliana da, et al.. (2021). Monitoring Emerging Human Immunodeficiency Virus Drug Resistance in Sub-Saharan Africa in the Era of Dolutegravir. The Journal of Infectious Diseases. 225(3). 364–366. 10 indexed citations
8.
Bachanas, Pamela, Mary Grace Alwano, Refeletswe Lebelonyane, et al.. (2021). Finding, treating and retaining persons with HIV in a high HIV prevalence and high treatment coverage country: Results from the Botswana Combination Prevention Project. PLoS ONE. 16(4). e0250211–e0250211. 5 indexed citations
9.
Godfrey, Catherine, Thomas Minior, B. Ryan Phelps, et al.. (2020). PEPFAR’s response to the convergence of the HIV and COVID‐19 pandemics in Sub‐Saharan Africa. Journal of the International AIDS Society. 23(8). e25587–e25587. 44 indexed citations
10.
Moyo, Sizulu, Gillian Hunt, Khangelani Zuma, et al.. (2020). HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey. PLoS ONE. 15(11). e0241071–e0241071. 20 indexed citations
11.
Mofenson, Lynne, Anton Pozniak, Elliot Raizes, et al.. (2019). Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects. Journal of the International AIDS Society. 22(7). e25352–e25352. 30 indexed citations
12.
Zhang, Guoqing, Sandra Medina-Moreno, Karidia Diallo, et al.. (2018). Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings. PLoS ONE. 13(9). e0203296–e0203296. 11 indexed citations
13.
Eymard‐Duvernay, Sabrina, Amandine Cournil, Laetitia Serrano, et al.. (2018). Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon. EClinicalMedicine. 1. 21–27. 26 indexed citations
14.
Sawadogo, Souleymane, Andrew L. Baughman, Adam Wolkon, et al.. (2018). Pretreatment HIV drug resistance among adults initiating ART in Namibia. Journal of Antimicrobial Chemotherapy. 73(11). 3137–3142. 17 indexed citations
15.
Dziuban, Eric J., Evelyn Ngugi, Guoqing Zhang, et al.. (2017). High Prevalence of Abacavir-associated L74V/I Mutations in Kenyan Children Failing Antiretroviral Therapy. The Pediatric Infectious Disease Journal. 36(8). 758–760. 4 indexed citations
16.
Hunt, Gillian, E. Kainne Dokubo, Simbarashe Takuva, et al.. (2017). Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa. Journal of Antimicrobial Chemotherapy. 72(11). 3222–3222. 4 indexed citations
17.
18.
Riley, Patricia L., et al.. (2016). Nursing and Midwifery Knowledge, Attitudes, and Practices Towards Viral Load Testing for Managing HIV‐Infected Patients in East, Central and Southern Africa. Journal of Midwifery & Women s Health. 61(5). 661–662. 3 indexed citations
19.
Dziuban, Eric J., Elliot Raizes, & Emilia H. Koumans. (2014). A farewell to didanosine: harm reduction and cost savings by eliminating use of didanosine. International Journal of STD & AIDS. 26(12). 903–906. 8 indexed citations
20.
Gupta, Somya, Reuben Granich, Amitabh B. Suthar, et al.. (2012). Global Policy Review of Antiretroviral Therapy Eligibility Criteria for Treatment and Prevention of HIV and Tuberculosis in Adults, Pregnant Women, and Serodiscordant Couples. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(3). e87–e97. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beth Chaplin Breakdown of academic impact, for papers by K. Naidu Breakdown of academic impact, for papers by Anne Esther Njom Nlend Breakdown of academic impact, for papers by Peter Arimi Breakdown of academic impact, for papers by Asghar Kheshti Breakdown of academic impact, for papers by Vincent Tukei Breakdown of academic impact, for papers by Joyceline Kinyua Breakdown of academic impact, for papers by Josephine Muhairwe Breakdown of academic impact, for papers by Roland O Swai Breakdown of academic impact, for papers by Grace Wariua
Rankless by CCL
2026